Systematic review of the neurobiological relevance of chemokines to psychiatric disorders

Frontiers in Cellular Neuroscience

Volumn 9, Issue September, 2015, Pages

  Stuart, Michael J ^a,b   Singhal, Gaurav ^a   Baune, Bernhard T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alzheimer s disease; Chemokine; Depression; Immune; Inflammation; Neurodegeneration; Neurogenesis; Schizophrenia

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; EOTAXIN; FRACTALKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; MONOCYTE CHEMOTACTIC PROTEIN 5; NEUROTRANSMITTER;

ALZHEIMER DISEASE; CD4+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; DEPRESSION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL DISEASE; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROENDOCRINE SYSTEM; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

EID: 84942912304     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00357     Document Type: Review

References (118)

1. Ahmed, F., Tessarollo, L., Thiele, C., and Mocchetti, I. (2008). Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain. Brain Res. 1227, 1-11. doi:10.1016/j.brainres.2008.05.086
2. Avdoshina, V., Becker, J., Campbell, L. A., Parsadanian, M., Mhyre, T., Tessarollo, L., et al. (2011). Neurotrophins modulate the expression of chemokine receptors in the brain. J. Neurovirol. 17, 58-62. doi:10.1007/s13365-010-0004-3
3. Bachstetter, A. D., Morganti, J. M., Jernberg, J., Schlunk, A., Mitchell, S. H., Brewster, K. W., et al. (2011). Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging 32, 2030-2044. doi: 10.1016/j.neurobiolaging.2009.11.022
4. Bagaeva, L. V., Rao, P., Powers, J. M., and Segal, B. M. (2006). CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 176, 7676-7685. doi:10.4049/jimmunol.176.12.7676
5. Baggiolini, M., Dewald, B., and Moser, B. (1997). Human chemokines: an update. Annu. Rev. Immunol. 15, 675-705. doi:10.1146/annurev.immunol.15.1.675
6. Bajetto, A., Bonavia, R., Barbero, S., Florio, T., and Schettini, G. (2001). Chemokines and their receptors in the central nervous system. Front. Neuroendocrinol. 22:147-184. doi:10.1006/frne.2001.0214
7. Banisadr, G., Frederick, T. J., Freitag, C., Ren, D., Jung, H., Miller, S. D., et al. (2011a). The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiol. Dis. 44, 19-27. doi:10.1016/j.nbd.2011.05.019
8. Banisadr, G., Bhattacharyya, B. J., Belmadani, A., Izen, S. C., Ren, D., Tran, P. B., et al. (2011b). The chemokine BRAK/CXCL14 regulates synaptic transmission in the adult mouse dentate gyrus stem cell niche. J. Neurochem. 119, 1173-1182. doi:10.1111/j.1471-4159.2011.07509.x
9. Banisadr, G., Gosselin, R. D., Mechighel, P., Rostene, W., Kitabgi, P., and Melik Parsadaniantz, S. (2005). Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J. Comp. Neurol. 492, 178-192. doi:10.1002/cne.20729
10. Banisadr, G., Queraud-Lesaux, F., Boutterin, M. C., Pelaprat, D., Zalc, B., Rostene, W., et al. (2002a). Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J. Neurochem. 81, 257-269. doi:10.1046/j.1471-4159.2002.00809.x
11. Banisadr, G., Fontanges, P., Haour, F., Kitabgi, P., Rostene, W., and Melik Parsadaniantz, S. (2002b). Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur. J. Neurosci. 16, 1661-1671. doi:10.1046/j.1460-9568.2002.02237.x
12. Baruch, K., Deczkowska, A., David, E., Castellano, J. M., Miller, O., Kertser, A., et al. (2014). Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science 346, 89-93. doi:10.1126/science.1252945
13. Betts, K. S., Williams, G. M., Najman, J. M., Scott, J., and Alati, R. (2014a). Exposure to stressful life events during pregnancy predicts psychotic experiences via behaviour problems in childhood. J. Psychiatr. Res. 59, 132-139. doi:10.1016/j.jpsychires.2014.08.001
14. Betts, K. S., Williams, G. M., Najman, J. M., Scott, J., and Alati, R. (2014b). Maternal prenatal infection, early susceptibility to illness and adult psychotic experiences: a birth cohort study. Schizophr. Res. 156, 161-167. doi: 10.1016/j.schres.2014.04.013
15. Blauth, K., Zhang, X., Chopra, M., Rogan, S., and Markovic-Plese, S. (2015). The role of fractalkine (CX3CL1) in regulation of CD4+ cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis. Clin. Immunol. 157, 121-132. doi:10.1016/j.clim.2015.01.001
16. Brown, A. S., Hooton, J., Schaefer, C. A., Zhang, H., Petkova, E., Babulas, V., et al. (2004). Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am. J. Psychiatry 161, 889-895. doi:10.1176/appi.ajp.161.5.889
17. Buschmann, J. P., Berger, K., Awad, H., Clarner, T., Beyer, C., and Kipp, M. (2012). Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelin-ation. J. Mol. Neurosci. 48, 66-76. doi:10.1007/s12031-012-9773-x
18. Callewaere, C., Banisadr, G., Rostene, W., and Parsadaniantz, S. M. (2007). Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. J. Mol. Endocrinol. 38, 355-363. doi:10.1677/JME-06-0035
19. Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., et al. (2006). Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-924. doi:10.1038/nn1715
20. Coughlan, C. M., McManus, C. M., Sharron, M., Gao, Z., Murphy, D., Jaffer, S., et al. (2000). Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97, 591-600. doi:10.1016/S0306-4522(00)00
21. Cowell, R. M., Xu, H., Galasso, J. M., and Silverstein, F. S. (2002). Hypoxic-ischemic injury induces macrophage inflammatory protein-1alpha expression in immature rat brain. Stroke 33, 795-801. doi:10.1161/hs0302.103740
22. Cyster, J. G. (1999). Chemokines and cell migration in secondary lymphoid organs. Science 286, 2098-2102. doi:10.1126/science.286.5447.2098
23. Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W., and Kelley, K. W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46-56. doi:10.1038/nrn2297
24. de Haas, A. H., Boddeke, H. W., and Biber, K. (2008). Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 56, 888-894. doi:10.1002/glia.20663
25. Denes, A, Ferenczi, S., Halasz, J., Kornyei, Z., and Kovacs, K. J. (2008). Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J. Cereb. Blood Flow Metab. 28, 1707-1721. doi:10.1038/jcbfm.2008.64
26. Di Prisco, S., Summa, M., Chellakudam, V., Rossi, P. I., and Pittaluga, A. (2012). RANTES-mediated control of excitatory amino acid release in mouse spinal cord. J. Neurochem. 121, 428-437. doi:10.1111/j.1471-4159.2012.07720.x
27. Dijkstra, I. M., de Haas, A. H., Brouwer, N., Boddeke, H. W., and Biber, K. (2006). Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo. Glia 54, 861-872. doi:10.1002/glia.20426
28. Dukart, J., Regen, F., Kherif, F., Colla, M., Bajbouj, M., Heuser, I., et al. (2014). Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders. Proc. Natl. Acad. Sci. U.S.A. 111, 1156-1161. doi:10.1073/pnas.1321399111
29. Eisch, A. J., and Petrik, D. (2012). Depression and hippocampal neurogenesis: a road to remission? Science 338, 72-75. doi:10.1126/science.1222941
30. Ellman, L. M., Deicken, R. F., Vinogradov, S., Kremen, W. S., Poole, J. H., Kern, D. M., et al. (2010). Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr. Res. 121, 46-54. doi:10.1016/j.schres.2010.05.014
31. Eltayeb, S., Berg, A. L., Lassmann, H., Wallstrom, E., Nilsson, M., Olsson, T., et al. (2007). Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms ofMOG-induced EAE. J. Neuroinflammation4, 14. doi:10.1186/1742-2094-4-14
32. Eyre, H., and Baune B. T. (2012). Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 37, 1397-1416. doi:10.1016/j.psyneuen.2012.03.019
33. Ferretti, E., Pistoia, V., and Corcione, A. (2014). Role of fractalkine/CX3CL1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on B cell malignancies. Mediators Inflamm. 2014, 480941. doi:10.1155/2014/480941
34. Flynn, G., Maru, S., Loughlin, J., Romero, I. A., and Male, D. (2003). Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136, 84-93. doi:10.1016/S0165-5728(03)00009-2
35. Foster, S. L., Talbot, S., and Woolf, C. J. C. N. S. (2015). Injury: IL-33 sounds the alarm. Immunity 42, 403-405. doi:10.1016/j.immuni.2015.02.019
36. Fuhrmann, M., Bittner, T., Jung, C. K., Burgold, S., Page, R. M., Mitteregger, G., et al. (2010). Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease. Nat. Neurosci. 13, 411-413. doi:10.1038/nn.2511
37. Gadani, S. P., Walsh, J. T., Smirnov, I., Zheng, J., and Kipnis, J. (2015). The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 85, 703-709. doi:10.1016/j.neuron.2015.01.013
38. Ge, S., Song, L., Serwanski, D. R., Kuziel, W. A., and Pachter, J. S. (2008). Transcellular transport of CCL2 across brain microvascular endothelial cells. J. Neurochem. 104, 1219-1232. doi:10.1111/j.1471-4159.2007.05056.x
39. Giovannelli, A., Limatola, C., Ragozzino, D., Mileo, A. M., Ruggieri, A., Ciotti, M. T., et al. (1998). CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 92, 122-132. doi:10.1016/S0165-5728(98)00192-1
40. Girotti, M., Donegan, J. J., and Morilak, D. A. (2011). Chronic intermittent cold stress sensitizes neuro-immune reactivity in the rat brain. Psychoneuroendocrinology 36, 1164-1174. doi:10.1016/j.psyneuen.2011.02.008
41. Gomez-Nicola, D., Pallas-Bazarra, N., Valle-Argos, B., and Nieto-Sampedro, M. (2010). CCR7 is expressed in astrocytes and upregulated after an inflammatory injury. J. Neuroimmunol. 227, 87-92. doi:10.1016/j.jneuroim.2010.06.018
42. Gordon, R. J., McGregor, A. L., and Connor, B. (2009). Chemokines direct neural progenitor cell migration following striatal cell loss. Mol. Cell. Neurosci. 41, 219-232. doi:10.1016/j.mcn.2009.03.001
43. Gottle, P., Kremer, D., Jander, S., Odemis, V., Engele, J., Hartung, H. P., et al. (2010). Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann. Neurol. 68, 915-924. doi:10.1002/ana.22214
44. Guyon, A., Skrzydelsi, D., Rovere, C., Rostene, W., Parsadaniantz, S. M., and Nahon, J. L. (2006). Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J. Neurochem. 96, 1540-1550. doi:10.1111/j.1471-4159.2006.03659.x
45. Harrison, E. L., Jaehne, E. J., Jawahar, M. C., Corrigan, F., and Baune B. T. (2014). Maternal separation modifies behavioural and neuroendocrine responses to stress in CCR7 deficient mice. Behav. Brain Res. 263, 169-175. doi: 10.1016/j.bbr.2014.01.036
46. Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., et al. (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U.S.A. 95, 10896-10901. doi:10.1073/pnas.95.18.10896
47. Hatori, K., Nagai, A., Heisel, R., Ryu, J. K., and Kim, S. U. (2002). Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 69, 418-426. doi:10.1002/jnr.10304
48. Hau, S., Reich, D. M., Scholz, M., Naumann, W., Emmrich, F., Kamprad, M., et al. (2008). Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neurosci. 9:30. doi:10.1186/1471-2202-9-30
49. Heinisch, S., and Kirby, L. G. (2009). Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuroscience 164, 1210-1223. doi:10.1016/j.neuroscience.2009.08.075
50. Heinisch, S., and Kirby, L. G. (2010). SDF-1alpha/CXCL12 enhances GABA and glutamate synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuropharmacology 58, 501-514. doi: 10.1016/j.neuropharm.2009.08.022
51. Hinojosa, A. E., Garcia-Bueno, B., Leza, J. C., and Madrigal, J. L. (2011). CCL2/MCP-1 modulation of microglial activation and proliferation. J. Neuroinflammation 8, 77. doi:10.1186/1742-2094-8-77
52. Hunter, S. K., Kisley, M. A., McCarthy, L., Freedman, R., and Ross, R. G. (2011). Diminished cerebral inhibition in neonates associated with risk factors for schizophrenia: parental psychosis, maternal depression, and nicotine use. Schizophr. Bull. 37, 1200-1208. doi:10.1093/schbul/sbq036
53. Imitola, J., Raddassi, K., Park, K. I., Mueller, F. J., Nieto, M., Teng, Y. D., et al. (2004). Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. U.S.A. 101, 18117-18122. doi:10.1073/pnas.0408258102
54. Inoue, K. (2006). The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol. Ther. 109, 210-226. doi: 10.1016/j.pharmthera.2005.07.001
55. Jaehne, E. J., and Baune B. T. (2014). Effects of chemokine receptor signalling on cognition-like, emotion-like and sociability behaviours of CCR6 and CCR7 knockout mice. Behav. Brain Res. 261, 31-39. doi: 10.1016/j.bbr.2013.12.006
56. Jaerve, A., and Muller, H. W. (2012). Chemokines in CNS injury and repair. Cell Tissue Res. 349, 229-248. doi:10.1007/s00441-012-1427-3
57. Jenh, C. H., Cox, M. A., Cui, L., Reich, E. P., Sullivan, L., Chen, S. C., et al. (2012). A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection. BMC Immunol. 13:2. doi:10.1186/1471-2172-13-2
58. Ji, J. F., He, B. P., Dheen, S. T., and Tay, S. S. (2004). Expression of chemokine receptors CXCR4, CCR2, CCR5 and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain. Neurosci. Lett. 355, 236-240. doi:10.1016/j.neulet.2003.11.024
59. Jo, W. K., Law, A. C., and Chung, S. K. (2014). The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocog-nitive disorders. Mol. Psychiatry 19, 159-167. doi:10.1038/mp.2013.171
60. Johnson, E. A., Dao, T. L., Guignet, M. A., Geddes, C. E., Koemeter-Cox, A. I., and Kan, R. K. (2011). Increased expression of the chemokines CXCL1 and MIP-1alpha by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J. Neuroinflammation 8, 41. doi:10.1186/1742-2094-8-41
61. Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., et al. (2000). Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106-4114. doi:10.1128/MCB.20.11.4106-4114.2000
62. Kan, A. A., van der Hel, W. S., Kolk, S. M., Bos, I. W., Verlinde, S. A., van Nieuwenhuizen, O., et al. (2012). Prolonged increase in rat hippocampal chemokine signalling after status epilepticus. J. Neuroimmunol. 245, 15-22. doi:10.1016/j.jneuroim.2012.01.012
63. Kang, J. X., and Gleason, E. D. (2013). Omega-3 fatty acids and hippocampal neurogenesis in depression. CNS Neurol. Disord. Drug Targets 12, 460-465. doi:10.2174/1871527311312040004
64. Kelland, E. E., Gilmore, W., Weiner, L. P., and Lund, B. T. (2011). The dual role of CXCL8 in human CNS stem cell function: multipotent neural stem cell death and oligodendrocyte progenitor cell chemotaxis. Glia 59, 1864-1878. doi:10.1002/glia.21230
65. Kerstetter, A. E., Padovani-Claudio, D. A., Bai, L., and Miller, R. H. (2009). Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp. Neurol. 220, 44-56. doi:10.1016/j.expneurol.2009.07.010
66. Kim, K. W., Vallon-Eberhard, A., Zigmond, E., Farache, J., Shezen, E., Shakhar, G., et al. (2011). In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood 118, e156-e167. doi: 10.1182/blood-2011-04-348946
67. Kim, T.-S., Lim, H.-K., Lee, J. Y., Kim, D.-J., Park, S., Lee, C., et al. (2008). Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer’s disease. Neurosci. Lett. 436, 196-200. doi:10.1016/j.neulet.2008.03.019
68. Klein, R. S., Izikson, L., Means, T., Gibson, H. D., Lin, E., Sobel, R. A., et al. (2004). IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. J. Immunol. 172, 550-559. doi:10.4049/jimmunol.172.1.550
69. Kokaia, Z., Martino, G., Schwartz, M., and Lindvall, O. (2012). Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat. Neurosci. 15, 1078-1087. doi:10.1038/nn.3163
70. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986). Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83, 4044-4048. doi: 10.1073/pnas.83.11.4044
71. Krathwohl, M. D., and Kaiser, J. L. (2004). Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22, 109-118. doi:10.1634/stemcells.22-1-109
72. Le, Y., Zhou, Y., Iribarren, P., and Wang, J. (2004). Chemokines and chemokine receptors: their manifold roles in homeostasis and disease. Cell. Mol. Immunol. 1, 95-104.
73. Lee, S., Xu, G., Jay, T. R., Bhatta, S., Kim, K.-W., Jung, S., et al. (2014). Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway. J. Neurosci. 34, 12538-12546. doi:10.1523/JNEUR0SCI.0853-14.2014
74. Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., G0tzsche, P. C., Ioannidis, J. P., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann. Intern. Med. 151, W-65-W-94. doi:10.7326/0003-4819-151-4-200908180-00136
75. Licinio, J. (2011). Translational psychiatry: leading the transition from the cesspool of devastation to a place where the grass is really greener. Transl. Psychiatry 1, e1. doi: 10.1038/tp.2011.3
76. Licinio, J., Wong, M. L., and Gold, P. W. (1992). Neutrophil-activating peptide-1/ interleukin-8 mRNA is localized in rat hypothalamus and hippocampus. Neuroreport 3, 753-756. doi:10.1097/00001756-199209000-00008
77. Liu, J. X., Cao, X., Tang, Y. C., Liu, Y., and Tang, F. R. (2007). CCR7, CCR8, CCR9 and CCR10 in the mouse hippocampal CA1 area and the dentate gyrus during and after pilocarpine-induced status epilepticus. J. Neurochem. 100, 1072-1088. doi:10.1111/j.1471-4159.2006.04272.x
78. Liu, Z., Condello, C., Schain, A., Harb, R., and Grutzendler, J. (2010). CX3CR1 in microglia regulates brain amyloid deposition through selective proto-fibrillar amyloid-p phagocytosis. J. Neurosci. 30, 17091-17101. doi:10.1523/JNEUROSCI.4403-10.2010
79. Ma, Q., Jones, D., Borghesani, P. R., Segal, R. A., Nagasawa, T., Kishimoto, T., et al. (1998). Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95, 9448-9453. doi:10.1073/pnas.95.16.9448
80. Martino, G., Pluchino, S., Bonfanti, L., and Schwartz, M. (2011). Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol. Rev. 91, 1281-1304. doi:10.1152/physrev.00032.2010
81. Melik-Parsadaniantz, S., and Rostene, W. (2008). Chemokines and neuromodulation. J. Neuroimmunol. 198, 62-68. doi:10.1016/j.jneuroim.2008.04.022
82. Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W., and Miller, R. J. (1998). Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 95, 14500-14505. doi:10.1073/pnas.95.24.14500
83. Miller, R. J., Rostene, W., Apartis, E., Banisadr, G., Biber, K., Milligan, E. D., et al. (2008). Chemokine action in the nervous system. J. Neurosci. 28, 11792-11795. doi:10.1523/JNEUROSCI.3588-08.2008
84. Mills, J. H., Alabanza, L. M., Mahamed, D. A., and Bynoe, M. S. (2012). Extracellular adenosine signaling induces CX3CL1 expression in the brain to promote experimental autoimmune encephalomyelitis. J. Neuroinflammation 9, 2094-2099. doi:10.1186/1742-2094-9-193
85. Mirabelli-Badenier, M., Braunersreuther, V., Viviani, G. L., Dallegri, F., Quercioli, A., Veneselli, E., et al. (2011). CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb. Haemost. 105, 409-420. doi:10.1160/TH10-10-0662
86. Moher, D., Liberati, A., Tetzlaff, J., and Altman, D. G. (2010). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 8, 336-341. doi:10.1016/j.ijsu.2010.02.007
87. Mordelet, E., Davies, H. A., Hillyer, P., Romero, I. A., and Male, D. (2007). Chemokine transport across human vascular endothelial cells. Endothelium 14, 7-15. doi:10.1080/10623320601177312
88. Moylan, S., Eyre, H. A., Maes, M., Baune B. T., Jacka, F. N., and Berk, M. (2013a). Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neurosci. Biobehav. Rev. 37, 573-584. doi: 10.1016/j.neubiorev.2013.02.003
89. Moylan, S., Maes, M., Wray, N. R., and Berk, M. (2013b). The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 18, 595-606. doi:10.1038/mp.2012.33
90. Moylan, S., Maes, M., Wray, N. R., and Berk, M. (2012). The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol. Psychiatry 18, 595-606. doi: 10.1038/mp.2012.33
91. Murdoch, C., and Finn, A. (2000). Chemokine receptors and their role in inflammation and infectious diseases. Blood 95, 3032-3043.
92. Murphy, C. A., Hoek, R. M., Wiekowski, M. T., Lira, S. A., and Sedgwick, J. D. (2002). Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain. J. Immunol. 169, 7054-7062. doi:10.4049/jimmunol.169.12.7054
93. Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., et al. (2000). International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145-176.
94. Naert, G., and Rivest, S. (2011). CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer’s disease. J. Neurosci. 31, 6208-6220. doi:10.1523/JNEUROSCI.0299-11.2011
95. Nelson, T. E., and Gruol, D. L. (2004). The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons. J. Neuroimmunol. 156, 74-87. doi:10.1016/j.jneuroim.2004.07.009
96. Nguyen, D., Hopfner, M., Zobel, F., Henke, U., Scherubl, H., and Stangel, M. (2003). Rat oligodendroglial cell lines express a functional receptor for the chemokine CCL3 (macrophage inflammatory protein-1alpha). Neurosci. Lett. 351, 71-74. doi:10.1016/j.neulet.2003.07.014
97. Omari, K. M., John, G. R., Sealfon, S. C., and Raine, C. S. (2005). CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 128(Pt 5), 1003-1015. doi:10.1093/brain/awh479
98. Omari, K. M., Lutz, S. E., Santambrogio, L., Lira, S. A., and Raine, C. S. (2009). Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am. J. Pathol. 174, 164-176. doi: 10.2353/ajpath.2009.080350
99. Ono, S. J., Nakamura, T., Miyazaki, D., Ohbayashi, M., Dawson, M., and Toda, M. (2003). Chemokines: roles in leukocyte development, trafficking, and effector function. J. Allergy Clin. Immunol. 111, 1185-1199. doi:10.1067/mai.2003.1594
100. Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., et al. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456-1458. doi:10.1126/science.1202529
101. Ubogu, E. E., Cossoy, M. B., and Ransohoff, R. M. (2006). The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol. Sci. 27, 48-55. doi: 10.1016/j.tips.2005.11.002
102. van der Meer, P., Ulrich, A. M., Gonzalez-Scarano, F., and Lavi, E. (2000). Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp. Mol. Pathol. 69, 192-201. doi:10.1006/exmp.2000.2336
103. Verburg-van Kemenade, B., Van der Aa, L., and Chadzinska, M. (2013). Neuroendocrine-immune interaction: regulation of inflammation via G-protein coupled receptors. Gen. Comp. Endocrinol. 188, 94-101. doi: 10.1016/j.ygcen.2012.11.010
104. Villa, P., Triulzi, S., Cavalieri, B., Di Bitondo, R., Bertini, R., Barbera, S., et al. (2007). The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats. Mol. Med. 13, 125-133. doi:10.2119/2007-00008.
105. Villa Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., et al. (2011). The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94. doi:10.1038/nature10357
106. Vukovic, J., Colditz, M. J., Blackmore, D. G., Ruitenberg, M. J., and Bartlett, P. F. (2012). Microglia modulate hippocampal neural precursor activity in response to exercise and aging. J. Neurosci. 32, 6435-6443. doi:10.1523/JNEUR0SCI.5925-11.2012
107. Walz, D. A., de Lamo, R., Dene, H., and McCoy, L. E. (1977). Primarystructure ofhuman platelet factor 4. Thromb. Res. 11, 893-898. doi:10.1016/0049-3848(77)90117-7
108. Watson, K., and Fan, G. H. (2005). Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinosi-tol 3-kinase signaling pathways. Mol. Pharmacol. 67, 757-765. doi: 10.1124/mol.104.004812
109. Weiss, J. M., Downie, S. A., Lyman, W. D., and Berman, J. W. (1998). Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J. Immunol. 161, 6896-6903.
110. Weiss, N., Deboux, C., Chaverot, N., Miller, F., Baron-Van Evercooren, A., Couraud, P. O., et al. (2010). IL8 and CXCL13 are potent chemokines for the recruitment of human neural precursor cells across brain endothelial cells. J. Neuroimmunol. 223, 131-134. doi:10.1016/j.jneuroim.2010.03.009
111. Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., et al. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet 382, 1575-1586. doi:10.1016/S0140-6736(13)61611-6
112. Widera, D., Holtkamp, W., Entschladen, F., Niggemann, B., Zanker, K., Kaltschmidt, B., et al. (2004). MCP-1 induces migration of adult neural stem cells. Eur. J. Cell Biol. 83, 381-387. doi:10.1078/0171-9335-00403
113. Wu, V.-Y., Walz, D. A., and McCoy, L. E. (1977). Purification and characterization of human and bovine platelet factor 4. Prep. Biochem. 7, 479-493. doi:10.1080/00327487708065515
114. Wu, Y., Peng, H., Cui, M., Whitney, N. P., Huang, Y., and Zheng, J. C. (2009). CXCL12 increases human neural progenitor cell proliferation through Akt-1/ F0X03a signaling pathway. J. Neurochem. 109, 1157-1167. doi: 10.1111/j.1471-4159.2009.06043.x
115. Yamagami, S., Tamura, M., Hayashi, M., Endo, N., Tanabe, H., Katsuura, Y., et al. (1999). Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. J. Leukoc. Biol. 65, 744-749.
116. Zhou, Y., Ling, E. A., and Dheen, S. T. (2007). Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J. Neurochem. 102, 667-678. doi:10.1111/j.1471-4159.2007.04535.x
117. Zlotnik, A., and Yoshie, O. (2000). Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127. doi:10.1016/S1074-7613(00)80165-X
118. Zou, Y.-R., Kottmann, A. H., Kuroda, M., Taniuchi, I., and Littman, D. R. (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599. doi:10.1038/31269